Atrás
Rango del Día
$31.34
$32.57
Rango de 52 Semanas
$19.34
$37.57
Volumen
545,508
Promedio 50D / 200D
$33.83
/
$29.01
Cierre Anterior
$31.78
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -8.1 | 0.4 |
| P/B | 11.2 | 2.9 |
| ROE % | -81.2 | 3.7 |
| Net Margin % | -18.6 | 3.9 |
| Rev Growth 5Y % | 12.9 | 10.0 |
| D/E | 13.5 | 0.2 |
Precio Objetivo de Analistas
Hold
$31.50
-0.4%
Low: $28.00
High: $35.00
EPS Futuro
-$5.09
Ingresos Est.
350 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$0.19
$0.19 – $0.19
|
550 M | 1 |
| FY2027 |
-$0.94
-$0.94 – -$0.94
|
370 M | 1 |
| FY2026 |
-$5.09
-$5.09 – -$5.09
|
350 M | 1 |
Puntos Clave
Revenue grew 12.88% annually over 5 years — strong growth
Debt/Equity of 13.46 — high leverage
Negative free cash flow of -8.92M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 12.36%
Capital efficient — spends only 8.73% of revenue on capex
Crecimiento
Revenue Growth (5Y)
12.88%
Revenue (1Y)25.24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-81.23%
ROIC-5.89%
Net Margin-18.57%
Op. Margin-15.27%
Seguridad
Debt / Equity
13.46
Current Ratio0.74
Interest Coverage-1.51
Valoración
P/E Ratio
-8.09
P/B Ratio11.17
EV/EBITDAN/A
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25.24% | Revenue Growth (3Y) | 22.18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12.88% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 381.14M | Net Income (TTM) | -70.78M |
| ROE | -81.23% | ROA | -8.38% |
| Gross Margin | -7.97% | Operating Margin | -15.27% |
| Net Margin | -18.57% | Free Cash Flow (TTM) | -8.92M |
| ROIC | -5.89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 13.46 | Current Ratio | 0.74 |
| Interest Coverage | -1.51 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | -8.09 | P/B Ratio | 11.17 |
| P/S Ratio | 1.50 | PEG Ratio | -0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.01% |
| Market Cap | 572.28M | Enterprise Value | 1.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 381.14M | 304.33M | 255.32M | 238.43M | 234.72M |
| Net Income | -70.78M | -2.06M | -21.11M | -54.40M | 125.61M |
| EPS (Diluted) | -4.22 | -0.54 | -3.85 | -9.27 | 37.92 |
| Gross Profit | -30.37M | 271.23M | 234.22M | 211.06M | 193.82M |
| Operating Income | -58.21M | -14.83M | -15.19M | -29.31M | -33.65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 844.85M | 841.92M | 621.46M | 661.27M | 728.55M |
| Total Liabilities | 788.59M | 712.31M | 688.01M | 719.43M | 734.11M |
| Shareholders' Equity | 51.24M | 123.03M | -66.55M | -58.16M | -5.56M |
| Total Debt | 689.74M | 651.39M | 629.42M | 671.03M | 683.68M |
| Cash & Equivalents | 11.01M | 16.99M | 4.08M | 16.91M | 78.69M |
| Current Assets | 77.88M | 64.09M | 32.35M | 43.57M | 106.19M |
| Current Liabilities | 105.13M | 75.62M | 100.86M | 94.32M | 120.48M |